Nutra Financial Statements From 2010 to 2025
Nutra Pharma financial statements provide useful quarterly and yearly information to potential Nutra Pharma Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nutra Pharma financial statements helps investors assess Nutra Pharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nutra Pharma's valuation are summarized below:Nutra Pharma Corp does not presently have any fundamental ratios for analysis.
This module can also supplement various Nutra Pharma Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Check Nutra Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutra Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nutra financial statements analysis is a perfect complement when working with Nutra Pharma Valuation or Volatility modules.
Nutra |
Nutra Pharma Corp Company Return On Asset Analysis
Nutra Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Nutra Pharma Return On Asset | -1.13 |
Most of Nutra Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutra Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Nutra Pharma Corp has a Return On Asset of -1.1323. This is 87.06% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Nutra Pharma Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutra Pharma's current stock value. Our valuation model uses many indicators to compare Nutra Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutra Pharma competition to find correlations between indicators driving Nutra Pharma's intrinsic value. More Info.Nutra Pharma Corp is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nutra Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nutra Pharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Nutra Pharma Financial Statements
Nutra Pharma stakeholders use historical fundamental indicators, such as Nutra Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nutra Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nutra Pharma's assets and liabilities are reflected in the revenues and expenses on Nutra Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nutra Pharma Corp. Please read more on our technical analysis and fundamental analysis pages.
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nutra Pink Sheet
Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.